12:00 AM
 | 
May 09, 2016
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Allob: Completed Phase IIa enrollment

Bone Therapeutics completed enrollment of 18 patients in an open-label, Belgian Phase IIa trial evaluating a single implantation of Allob mixed with bioceramic granules. The study enrolled patients with symptomatic degenerative lumbar disc disease that...

Read the full 153 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >